MRNA vs TBI · rev $145.0M vs rev $841.6M
Moderna Inc (MRNA) versus TrueBlue Inc (TBI) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
TrueBlue Inc (TBI) is a staffing & employment services company listed on NYSE.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported TBI revenue for 2026-06-28 was $841.6M. Net income was -$23.2M. TBI currently screens at market cap $205.8M.
MRNA currently screens at market cap $24.52B. TBI currently screens at market cap $205.8M.
Not investment advice. Open the MRNA and TBI stock pages for the full models.
Not investment advice.